MSD Ukraine


Multinational biopharmaceutical company engaged in discovery, development and delivery of medicines and vaccines. The Ukraine site emphasizes research and development across oncology, vaccines and infectious diseases; sponsorship and conduct of clinical trials (Phases I–IV) in Ukraine; regulatory submissions and pharmacovigilance; business development and licensing; and programs to expand access to medicines including production scale-up and voluntary licensing during public health emergencies.

Industries

N/A

MSD Ukraine


Products

Vaccines (multiple indications)

Development and global supply of vaccines for prevention of infectious diseases using recombinant and other vaccine technologies.

Therapeutic medicines (oncology, antivirals, cardiometabolic, immunology)

Research, development and supply of small-molecule and biologic therapeutics across oncology, infectious diseases and cardiometabolic indications.

Animal health products

Development and supply of products for animal health and veterinary use.


Services

Clinical development and trial sponsorship

Sponsorship and management of clinical trials across phases I–IV in multiple therapeutic areas in Ukraine and globally, including local site management and participant monitoring.

Research partnerships, licensing and external BD support

Collaboration and licensing for external discoveries across discovery and clinical stages, with a dedicated business development and licensing contact channel for external innovators.

Access programs, donations and voluntary licensing

Programmatic partnerships, donations through multilateral channels and voluntary licensing arrangements to increase availability of medicines in low- and middle-income countries.

Pandemic manufacturing and supply coordination

Advance manufacture and allocation of therapeutic courses, coordination of global supply chains and procurement agreements with governments and multilateral purchasers.

Expertise Areas

  • Clinical trial management and site operations (Phases I–IV)
  • Oncology research and immuno-oncology
  • Vaccine research, development and manufacturing
  • Infectious disease therapeutics and antiviral development
  • Show More (6)

Key Technologies

  • Recombinant vaccine platforms
  • Vaccine manufacturing processes and scale-up
  • Oral nucleoside-analog antiviral development
  • Small-molecule drug development
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.